p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinomaBarbro Linderholm, Roger Henriksson, Kjell Grankvist et al.|International Journal of Cancer|2000Cited by 155
Epirubicin cytotoxicity but not oxygen radical formation is enhanced by four different antiemeticsRoger Henriksson, Kjell Grankvist|Medical Oncology and Tumor Pharmacotherapy|1989Cited by 8